FQHC & Tribal Health Edition
Closing the Diabetic Retinopathy Screening Gap
For Medicare and Medicaid patients, CPT 92229 is bundled into the FQHC PPS encounter, the APM capitation, or the IHS AIR. There is no separately payable per-screen fee. For commercial patients, billing is contract-dependent and varies by payer; some large commercial plans mirror PPS at FQHCs, others pay fee-for-service. The financial case stacks three things: net-new qualifying encounters (cleanly via AWV pull-through), HEDIS / GPRA quality measure performance, and APM or SDPI grant participation protection. This calculator models all three.

1 Organization & Geography Step 1

ZIP optional
State
CMS Locality for Medicare GAF
ZIP auto-fills State and CMS Locality. Locality picks the Medicare GAF that adjusts the PPS encounter rate. All 50 states + DC supported. Picking a state-specific APM lane (CalAIM or OR / WA APM) will auto-set the state to match.
Number of locations one subscription per site
One AEYE-DS subscription per clinic location. A multi-site FQHC with four clinics enters 4 here; the subscription cost line below multiplies accordingly.

! How 92229 Actually Pays at an FQHC or Tribal Facility

1
Encounter Capture
Every diabetic patient who would have been referred out for retinal screening is now an in-clinic encounter you bill at your FQHC PPS rate (~$208 Medicare; state Medicaid is contract-dependent and varies widely by facility and plan) or your IHS AIR (~$733 Medicare-side / $826 non-Medicare CY 2026). 92229 does NOT add a separate fee; the encounter does. AWV pull-through (screen during AWV) is the cleanest tactical play.
2
Quality Measure Performance
HEDIS Eye Exam for Patients with Diabetes (EED) for FQHCs, GPRA DR Screening Rate for Tribal / IHS. Both drive MCO pay-for-performance (typically 1 to 2 percent of plan value, contract-specific) and feed state accountability sets like California MCAS.
3
APM / Grant Participation Protection
For FQHCs in CalAIM / Oregon / Washington APMs: sustained quality performance is a CONDITION of staying in the APM. Falling below threshold reverts you to PPS billing, a structural revenue change. For Tribal: DR screening rate is built into SDPI grant scope of work, and sustained low rates affect grant scope and renewal.
The per-screen Medicare rate of $40 to $55 (the figure quoted online for CPT 92229) applies to non-FQHC physician offices, NOT to FQHCs or Tribal Health Programs for Medicare and Medicaid patients. For Medicare and Medicaid patients, the encounter is the revenue unit and 92229 is bundled in. A standalone DR screening visit without a qualifying-practitioner face-to-face does not trigger a PPS or AIR encounter under 42 CFR 405.2463. Commercial / private insurance at FQHCs is NOT governed by federal PPS rules; it is contract-dependent, and a minority of commercial contracts pay 92229 fee-for-service. Confirm each of your top commercial payer contracts with your billing director.
Quick estimate Sensible defaults pre-loaded. Toggle on to refine.

2 Diabetic Panel Step 2

Diabetic Patients (Age 22 to 75) FDA-cleared
Adults with diabetes in your active panel. Age 22 is the FDA-cleared lower bound for CPT 92229 autonomous DR screening; 75 is the upper bound of the HEDIS Eye Exam for Diabetes measure.
Total Active Panel if you'd rather start here
Total active patients. Diabetic count will be estimated at 20% if you edit this.

3 EED Screening Rate, Current vs Target Step 3

Set your current HEDIS EED rate and the target rate. The gap drives quality measure performance (HEDIS for FQHCs, GPRA for Tribal). Encounter capture is modeled separately below since 92229 is bundled into the encounter.
Current EED Rate
42%
National FQHC median ~50%, UDS goal ≥ 71%.
Target EED Rate
71%
71% = HRSA UDS top quartile. 90%+ is achievable with in-clinic autonomous screening.
 
% of EED closures that drive a NET-NEW qualifying encounter key
35%
Per the briefs: encounter capture comes from (a) avoided external referrals (patients who would have been referred out for screening, now retained as in-clinic encounters), and (b) proactive outreach that drives net-new qualifying visits (AWV pull-through is the canonical play). Patients who were coming in for chronic care anyway do not add incremental encounter revenue; 92229 just closes the quality measure on those. Conservative default: 35%.
Patient-care value (qualitative)
Closing the EED gap also closes the retina-care loop for patients who would otherwise leak to incomplete external referrals. National referral-completion rates run 50 to 65 percent in urban settings and lower in rural / reservation-based panels. The closed gap that does NOT translate to a billable encounter still translates to patients who get diabetic eye exams they would have missed.

4 Payer Mix Advanced

For Medicare and Medicaid lines, the rate column is the FQHC PPS or IHS AIR ENCOUNTER rate, not a per-screen fee. How CPT 92229 itself is reimbursed under your state Medicaid is contract-dependent. Under FQHC PPS (state Medicaid fee-for-service), 92229 is bundled into the encounter and is not separately payable. Under Medicaid managed care, each Medicaid Managed Care Plan (MCP) contract governs whether 92229 is bundled into the negotiated encounter rate, separately payable as a line item, or required in a specific form to earn EED quality credit. It is not a uniform statewide rule, it varies plan by plan. Commercial insurance is likewise governed by individual payer contracts, NOT federal PPS or AIR. The rate defaults shown are illustrative placeholders. Type in your own percentages and your actual contracted rates; percentages auto-balance to 100% when you click out. Tribal IHS lane: AIR applies only to AI/AN attributed beneficiaries; commercial defaults to your commercial rate.
Share of diabetic patients (type the % and the encounter rate, both are editable) Total: 100%
Medicare FFSCPT 92229 inside the FQHC PPS encounter
Medicare AdvantagePPS wraparound, plus MA P4P upside
Medicaid FFSState PPS, facility-specific (cost-report based)
Medicaid Managed Care92229 treatment set by each MCP contract
CommercialContract-specific; varies by payer

5 MCO Pay-for-Performance (EED-specific share) Advanced

Medicaid MCOs put 1 to 2 percent of contract value at risk for HEDIS quality overall. EED (Eye Exam for Patients with Diabetes) is one of roughly 15 to 20 measures in that pool, typically weighted at 8 to 15 percent. The math below isolates the EED-specific earn-back, which is what 92229 directly drives.
MCO Quality Pool (% of premium at risk, all HEDIS measures)
1.5%
Range 0 to 3% of premium. Contract-specific. Default 1.5% reflects mid-range CA / OR / WA Medicaid HEDIS quality withholds.
EED measure weighting in the HEDIS pool
12%
Share of the HEDIS quality pool attributed to EED specifically. Range 5 to 25% in published MCO scorecards. Higher in diabetic-heavy populations or where EED is a state-priority measure.
MCO PMPY Premium avg per attributed member
/yr
Used to size the quality pool. Medicaid managed care typical $3,500 to $6,500 PMPY (varies by state and population).
Tribal Health, GPRA & SDPI
Visible because you selected a Tribal lane. For Tribal Health Programs, the primary value of autonomous DR screening is patient care (closes the referral-completion gap for rural / reservation-based panels), GPRA measure 17 (DR screening) reporting performance, and SDPI grant scope-of-work protection. Encounter capture at AIR is meaningful but secondary. Sustained low DR screening rates affect SDPI grant renewal positioning.
Current GPRA DR Rate
38%
IHS national avg ~38% (FY2023 GPRA). Top sites ≥ 70%.
Target GPRA DR Rate
70%
SDPI grants increasingly require ≥ 70% GPRA diabetes measures.
SDPI Grant Value site-specific
/yr
Annual SDPI funding tied to diabetes programming. FY2025 federal appropriation is $160M across 301 grantees (~$531k average), but actual awards vary widely from $100k to $2M+. Placeholder, enter your specific award amount.
SDPI Risk Buffer % you want to protect
15%
Estimated portion of SDPI at risk if DR screening falls short of program targets. Conservative 15% default.

6 AWV Pull-Through (boosted encounter) Advanced

An autonomous DR screen frequently sits inside a Medicare Annual Wellness Visit. The AWV / IPPE / new-patient encounter triggers a 34.16% PPS bump (CY 2026 = $271.88 vs $207.72 base).
Diabetic Medicare AWV uptake
% of Medicare diabetics without an AWV in last 12 mo
55%
National Medicare AWV uptake ~45%; FQHC AWV uptake lags. Adjust to your data.
% of that gap you'd close alongside DR screening
40%
Conservative 40%, not every diabetic walking in for a screen converts to a full AWV.
-

7 Revenue & Quality Impact (Annualized) Result

Encounter Capture (net-new visits)
$0
-
Quality Measure Performance Value
$0
-
APM / Grant Participation
-
-
 
AEYE-DS subscription $ /mo per location × 1 location = $1,350/mo
-$16,200 / year
Net Annual Impact (after subscription)
$0
Encounter capture + quality measure value, minus the AEYE-DS annual subscription. APM / grant participation status shown qualitatively, the dollar value of protection is not quantified. All figures are directional planning estimates, not a quote.
What to verify with your billing director (click to expand)
  1. Commercial payer contract terms. For each of your top commercial payers, confirm whether the contract pays per-encounter (PPS-equivalent) or fee-for-service. If FFS, 92229 may be billable as a separate line at the contracted rate.
  2. 92229 PC/TC indicator on the current CMS MPFS RVU file. If indicator is 9 (concept does not apply, global only), 92229 is fully bundled into Medicare FQHC PPS. If indicator is 1 (separable PC and TC), the technical component can be carved out and billed separately to Part B on a CMS-1500. Your MAC is authoritative.
  3. State Medicaid technical-component carve-outs. Some state Medicaid manuals carve out technical components of diagnostic services from FQHC PPS bundling. Check your state Medicaid FQHC billing manual.
  4. Medicaid MCO HEDIS / value-based bonus terms. Wraparound to PPS is statutory floor; HEDIS EED bonuses on top vary by MCO contract. Confirm the bonus structure for each MCO contract.
  5. How 92229 is reimbursed under each Medicaid Managed Care Plan. Under Medicaid FFS, 92229 is bundled into the FQHC PPS encounter. Under managed care it is contract-dependent: confirm, per Medicaid Managed Care Plan contract, whether 92229 is bundled into the negotiated rate, separately payable, or required in a specific form to earn EED quality credit. It is not a uniform rule. If you are on a state APM (CalAIM in CA, APM 2B in OR, APM4 in WA, etc.), a per-member capitation replaces encounter billing.
  6. Oregon APCM enrollment. If your FQHC is on Oregon's APCM (Alternative Payment and Advanced Care Model), primary care is paid per-member-per-month not per-encounter. 92229 is within the PMPM, not additive.
  7. For Tribal Health Programs: commercial reimbursement at IHS-direct and Tribal 638 facilities is NOT governed by AIR. Confirm each commercial contract.
  8. Self-pay sliding fee. Self-pay patients under your HRSA-compliant sliding fee discount program are billed line-item from your full fee schedule with the sliding discount applied, NOT at the encounter rate. Net collections are typically low.